Compare WRN & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WRN | DNA |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | Canada | United States |
| Employees | N/A | 485 |
| Industry | Metal Mining | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.2M | 599.0M |
| IPO Year | 2006 | N/A |
| Metric | WRN | DNA |
|---|---|---|
| Price | $2.15 | $9.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | $4.58 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 1.9M | 1.1M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.19 | $5.37 |
| 52 Week High | $4.26 | $17.58 |
| Indicator | WRN | DNA |
|---|---|---|
| Relative Strength Index (RSI) | 37.08 | 50.73 |
| Support Level | $2.04 | $7.59 |
| Resistance Level | $2.61 | $10.05 |
| Average True Range (ATR) | 0.11 | 0.85 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 17.50 | 41.87 |
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project). The Casino can deliver the critical minerals necessary for the energy transition while serving as an engine for long-term economic growth and prosperity in the North.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.